ghk cu aliquot GHK-CU 30mg – 100mL Topical GHK-CU :: Aurapeptides

For example, reduced BDNF levels have been detected in the brains of patients with neurodegenerative disorders such as Alzheimers disease 4 , Parkinsons disease 5 , and Huntingtons disease 6 , as well as neuropsychiatric disorders such as depression 7 and schizophrenia 8

Research grade indicates the material is supplied for laboratory research workflows with analytical documentation (such as HPLC purity and CoA), and is not intended for clinical, therapeutic, or cosmetic use

Analytical verification requires reverse-phase HPLC with UV detection at 214-220 nm to confirm retention time consistency and peak purity above 95%, while mass spectrometry (MALDI-TOF or ESI-MS) can confirm the expected molecular ion at 1419.53 Da and identify any truncation or oxidation products

These requirements add to manufacturing costs and complexity